The equine rabies immunoglobulin (ERIG) market is anticipated to grow at a significant CAGR of 4.4% during the forecast period (2022-2028). ERIG is a hyperimmune globulin made from persons who have been inoculated against rabies and have extremely high antibody titers. The ERIG is used to treat people who have been exposed to rabid animals. […]
